Kustom Entertainment, Inc. filed a Form 8-K on November 9, 2026, disclosing that it entered into an amendment to its Unit Purchase Agreement with TFL, LLC on November 6, 2026, extending the outside termination date for the proposed transaction to December 18, 2026.
ArriVent BioPharma, Inc. filed a Form 8-K on November 9, 2026, disclosing the planned retirement of President of Research and Development Stuart Lutzker, M.D., Ph.D., effective December 1, 2026, along with the appointment of Chief Medical Officer Priti Patel, M.D., to lead the company's …
Park Dental Partners, Inc. filed an 8-K on November 9, 2026, reporting the November 6, 2026 completion of its acquisition of the dental services organization supporting Village Family Dental and the related amendment to its credit facility.
Sanmina Corporation filed a Form 8-K on November 9, 2026, disclosing Amendment No. 5 to its senior secured credit agreement, which added $70 million in incremental term loans and extended the maturity of key credit facilities to October 28, 2031, while also announcing unaudited …
SciSparc Ltd. filed a Form F-3 registration statement with the SEC on November 9, 2026, covering the resale of up to 76,807,229 ordinary shares by a selling shareholder in connection with a convertible promissory note and accompanying warrant issued under a securities purchase agreement …
Cresud S.A.C.I.F. and A. filed a Form 6-K with the SEC on November 9, 2026, reporting first-quarter fiscal year 2027 financial highlights and equity details as of September 30, 2026, in compliance with Article 63 of the Buenos Aires Stock Exchange Regulations.
Wheeler Real Estate Investment Trust, Inc. filed a Form 8-K on November 9, 2026, disclosing unregistered sales of equity securities in connection with two separate exchange transactions on November 3 and November 6, 2026, in which an aggregate of approximately 1,167,880 shares of common …
DocGo Inc. filed a Form 8-K with the SEC on November 9, 2026, announcing the release of its earnings results for the quarter ended September 30, 2026, along with a conference call held that same day.
Phoenix Asia Holdings Limited filed a Form 6-K on November 9, 2026, disclosing that it terminated its Stock Acquisition Agreement with ACEA Pharma, Inc. and ACEA Therapeutics, Inc., effective November 3, 2026.
Barclays PLC furnished a Form 6-K to the U.S. Securities and Exchange Commission on November 9, 2026, disclosing a Pricing Agreement and related indenture documents for its 8.625% Fixed Rate Resetting Perpetual Subordinated Contingent Convertible Securities.